Alpha Paradigm Partners’s Amgen AMGN Stock Holding History

Alpha Paradigm Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$295K	Sell	1,123 -677	-38%	-$181K	0.12%	254
2022 Q3	$406K	Buy	1,800 +1,168	+185%	+$283K	0.18%	188
2022 Q2	$154K	Sell	632 -592	-48%	-$145K	0.06%	352
2022 Q1	$296K	Buy	1,224 +976	+394%	+$224K	0.12%	273
2021 Q4	$56K	Sell	248 -4,809	-95%	-$1.01M	0.02%	470
2021 Q3	$1.07M	Buy	5,057 +4,821	+2,043%	+$1.11M	0.43%	55
2021 Q2	$58K	Buy	+236	New	+$58.1K	0.02%	469
2021 Q1	–	Sell	-1,688	Closed	-$388K	–	482
2020 Q4	$388K	Buy	+1,688	New	+$389K	0.13%	188

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alpha Paradigm Partners's AMGN Position: Q4 2022 in Review

Alpha Paradigm Partners reduced its Amgen (AMGN) stake by 38% in Q4 2022, selling an estimated $181K and leaving 1,123 shares worth $295K. The position accounts for 0.12% of the portfolio, ranked #254.

Alpha Paradigm Partners first reported a position in AMGN in Q4 2020 and has held it in 8 quarters since. The position peaked at $1.07M in Q3 2021. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

Alpha Paradigm Partners held 1,123 shares of Amgen worth $295K as of Q4 2022.
Alpha Paradigm Partners sold 677 Amgen shares in Q4 2022, an estimated $181K.
Amgen made up 0.12% of Alpha Paradigm Partners's portfolio in Q4 2022, its #254 holding.
Alpha Paradigm Partners first reported a position in Amgen in Q4 2020 and has held it in 8 quarters since.
Alpha Paradigm Partners's Amgen position peaked at $1.07M in Q3 2021.
2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.